Abstract

PARP-1 is rapidly recruited and activated by DNA double-strand breaks (DSBs). Upon activation, PARP-1 synthesizes a structurally complex polymer composed of ADP-ribose units that facilitates local chromatin relaxation and the recruitment of DNA repair factors. Here, we identify a function for PARP-1 in DNA DSB resection. Remarkably, inhibition of PARP-1 leads to hyperresected DNA DSBs. We show that loss of PARP-1 and hyperresection are associated with loss of Ku, 53BP1 and RIF1 resection inhibitors from the break site. DNA curtains analysis show that EXO1-mediated resection is blocked by PARP-1. Furthermore, PARP-1 abrogation leads to increased DNA resection tracks and an increase of homologous recombination in cellulo. Our results, therefore, place PARP-1 activation as a critical early event for DNA DSB repair activation and regulation of resection. Hence, our work has direct implications for the clinical use and effectiveness of PARP inhibition, which is prescribed for the treatment of various malignancies.

Details

Title
Poly(ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks
Author
Caron, Marie-Christine 1 ; Sharma, Ajit K 2 ; Julia O’Sullivan 1 ; Myler, Logan R 3 ; Ferreira, Maria Tedim 4 ; Rodrigue, Amélie 1 ; Coulombe, Yan 1 ; Ethier, Chantal 4 ; Gagné, Jean-Philippe 4 ; Langelier, Marie-France 5 ; Pascal, John M 5 ; Finkelstein, Ilya J 3   VIAFID ORCID Logo  ; Hendzel, Michael J 2   VIAFID ORCID Logo  ; Poirier, Guy G 4 ; Masson, Jean-Yves 1 

 Genome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Division, Québec City, QC, Canada; Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada 
 Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AL, Canada 
 Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA 
 Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, QC, Canada; CHU de Québec Research Center, CHUL Pavilion, Oncology Division, Québec City, QC, Canada 
 Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada 
Pages
1-16
Publication year
2019
Publication date
Jul 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2252267633
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.